0001104659-24-088925.txt : 20240813
0001104659-24-088925.hdr.sgml : 20240813
20240813160110
ACCESSION NUMBER: 0001104659-24-088925
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240811
FILED AS OF DATE: 20240813
DATE AS OF CHANGE: 20240813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kim Hyung Heon
CENTRAL INDEX KEY: 0001873258
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 241201211
MAIL ADDRESS:
STREET 1: C/O DONG-A ST & DONG-A SOCIO GROUP
STREET 2: 64 CHEONHO DAERO, DONGDAEMUN-GU
CITY: SEOUL
STATE: M5
ZIP: 00000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 545 CONCORD AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
BUSINESS PHONE: (857) 702-9600
MAIL ADDRESS:
STREET 1: 545 CONCORD AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
FORMER COMPANY:
FORMER CONFORMED NAME: Gemphire Therapeutics Inc.
DATE OF NAME CHANGE: 20150331
4
1
tm2421534-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-08-11
0
0001638287
NeuroBo Pharmaceuticals, Inc.
NRBO
0001873258
Kim Hyung Heon
C/O NEUROBO PHARMACEUTICALS, INC.
545 CONCORD AVENUE, SUITE 210
CAMBRIDGE
MA
02138
1
1
0
0
CEO & President
0
Common Stock
2024-08-11
4
F
0
11467
3.60
D
66666
D
Shares were withheld by the Issuer in satisfaction of the Reporting Person's tax liabilities in connection with the vesting of restricted stock units, based on the Issuer's closing price on August 9, 2024.
The total number of securities beneficially owned has been adjusted to reflect the Issuer's completion of a 1-for-8 reverse stock split on December 20, 2023.
/s/ Phillip D. Torrence, by Power of Attorney
2024-08-13